Skip to main content

Table 2 Correlation between the clinicopathological features and expression of HOXD3

From: Nuclear lncRNA HOXD-AS1 suppresses colorectal carcinoma growth and metastasis via inhibiting HOXD3-induced integrin β3 transcriptional activating and MAPK/AKT signalling

clinicopathological variables

N

low(%)

high(%)

χ2

P value

All cases

164

79

85

Gender

 male

89

41 (46.1)

48 (53.9)

0.345

0.638

 female

75

38 (50.7)

37 (49.3)

Age(years)

  < 56

72

37 (51.4)

35 (48.6)

0.532

0.53

  ≥ 56

92

42 (45.7)

50 (54.3)

Tumor size(cm)

  < 5

96

45 (46.9)

51 (53.1)

0.156

0.752

  ≥ 5

68

34 (50.0)

34 (50.0)

Tumor differentiation

 Good

56

29 (51.8)

27 (48.2)

1.447

0.485

 Moderate

77

38 (49.4)

39 (50.6)

 Poor

31

12 (38.7)

19 (61.3)

T-stage

 T1-T2

31

20 (64.5)

11 (35.5)

4.397

0.111

 T3

127

57 (44.9)

70 (55.1)

 T4

6

2 (33.3)

4 (66.7)

N-stage

 0

98

54 (55.1)

44 (44.9)

4.686

0.038

 1–2

66

25 (37.9)

41 (62.1)

M-stage

 0

152

77 (50.7)

75 (49.3)

5.147

0.033

 1

12

2 (16.7)

10 (83.3)